Cardioxyl Pharmaceuticals
Latest round
- Series B
Last raised
- Nov 2012
Total raised
- $61M
Investors
- 4
About Cardioxyl Pharmaceuticals
Founded in 2005 and headquartered in Chapel Hill, US, Cardioxyl Pharmaceuticals specializes in cardiovascular therapeutics. In November 2015, Bristol-Myers Squibb acquired Cardioxyl Pharmaceuticals.Cardioxyl Pharmaceuticals specializes in creating advanced therapeutic solutions aimed at treating cardiovascular conditions. The company’s key product offerings include innovative drug formulations designed to improve heart health and patient outcomes. Its solutions cater to healthcare providers and institutions, addressing critical needs in cardiac care.Cardioxyl Pharmaceuticals operates on a revenue model centered around the sale of its pharmaceutical products, providing access to its innovative therapies through various partnerships with healthcare systems and providers. This model enables consistent revenue streams and promotes long-term relationships with clients.Cardioxyl Pharmaceuticals aims to expand its portfolio with new cardiovascular therapeutic products, with several under development expected to launch by late 2026. The company plans to extend its market reach into Europe and Asia, targeting these regions for expansion by 2027.
Who invested in Cardioxyl Pharmaceuticals
4 investors across 5 rounds
See all investors in Cardioxyl Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cardioxyl Pharmaceuticals
Who invested in Cardioxyl Pharmaceuticals?
Cardioxyl Pharmaceuticals has 4 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cardioxyl Pharmaceuticals raised?
Cardioxyl Pharmaceuticals has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Cardioxyl Pharmaceuticals last raise money?
Cardioxyl Pharmaceuticals's most recent round on record is a Series B, in Nov 2012.
What does Cardioxyl Pharmaceuticals do?
Founded in 2005 and headquartered in Chapel Hill, US, Cardioxyl Pharmaceuticals specializes in cardiovascular therapeutics.
Where is Cardioxyl Pharmaceuticals headquartered?
Cardioxyl Pharmaceuticals is headquartered in Chapel Hill, US.
Which VCs invest in companies like Cardioxyl Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Cardioxyl Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Cardioxyl Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.